文献速递临床试验与 GCP流行病学与生物统计

基于社区的肿瘤内科抑郁筛查项目对乳腺癌患者行为健康转诊的影响:一项随机临床试验

Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2022-01-01

在Kaiser Permanente南加州6个医疗中心开展实用整群随机试验,1436例新发原发性乳腺癌患者按中心1:1分为定制实施策略组(744例)与仅教育对照组(692例)。定制组转诊率7.9%(59/744),对照组0.1%(1/692),差异7.8%(95%CI 5.8%-9.8%)。

要点

  • 定制实施策略组行为健康转诊率7.9%(59/744),仅教育对照组0.1%(1/692),差异7.8%(95%CI 5.8%-9.8%)。
  • 定制组完成行为健康临床医生转诊44/59(75%),对照组1/1(100%)。
  • 调整模型显示定制组肿瘤内科门诊就诊率比0.86(95%CI 0.86-0.89;P=0.001),其他就诊无显著差异。

核心结论

  • 在社区肿瘤实践中,与仅教育对照组相比,定制实施策略用于常规抑郁筛查使更多患者转诊至行为健康服务。
  • 需要进一步研究以了解该项目的临床获益和成本效益。

研究设计与样本

  • 实用整群随机临床试验,在Kaiser Permanente南加州(KPSC)6个医疗中心开展,中心按1:1随机分入定制实施策略组(3个中心,744例)或仅教育对照组(3个中心,692例)。
  • 纳入1436例于2017年10月1日至2018年9月30日期间与肿瘤内科会诊的新发原发性乳腺癌患者,随访至研究结束日期2019年5月31日。
  • 干预组接受项目教育、绩效数据审计与反馈及实施促进,并根据本地情况调整临床工作流程;对照组仅接受项目教育。

主要发现

  • 主要结局:定制实施策略组转诊率7.9%(59/744),仅教育对照组0.1%(1/692),差异7.8%(95%CI 5.8%-9.8%)。
  • 完成行为健康临床医生转诊:定制组44/59(75%),对照组1/1(100%)。
  • 调整模型:定制组肿瘤内科门诊就诊率比0.86(95%CI 0.86-0.89;P=0.001),初级保健、急诊护理和急诊科就诊利用率无显著差异。

关键数值与推荐

  • 项目包括使用9项患者健康问卷(PHQ-9)筛查,基于低、中、高分进行算法评分并转诊至行为健康服务。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究以了解该项目的临床获益和成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Implementation of guideline-recommended depression screening in medical oncology remains challenging. Evidence suggests that multicomponent care pathways with algorithm-based referral and management are effective, yet implementation of sustainable programs remains limited and implementation-science guided approaches are understudied. OBJECTIVE: To evaluate the effectiveness of an implementation-strategy guided depression screening program for patients with breast cancer in a community setting. DESIGN, SETTING, AND PARTICIPANTS: A pragmatic cluster randomized clinical trial conducted within Kaiser Permanente Southern California (KPSC). The trial included 6 medical centers and 1436 patients diagnosed with new primary breast cancer who had a consultation with medical oncology between October 1, 2017, through September 30, 2018. Patients were followed up through study end date of May 31, 2019. INTERVENTIONS: Six medical centers in Southern California participated and were randomized 1:1 to tailored implementation strategies (intervention, 3 sites, n = 744 patients) or education-only (control, 3 sites, n = 692 patients) groups. The program consisted of screening with the 9-item Patient Health Questionnaire (PHQ-9) and algorithm-based scoring and referral to behavioral health services based on low, moderate, or high score. Clinical teams at tailored intervention sites received program education, audit, and feedback of performance data and implementation facilitation, and clinical workflows were adapted to suit local context. Education-only controls sites received program education. MAIN OUTCOMES AND MEASURES: The primary outcome was percent of eligible patients screened and referred (based on PHQ-9 score) at intervention vs control groups measured at the patient level. Secondary outcomes included outpatient health care utilization for behavioral health, primary care, oncology, urgent care, and emergency department. RESULTS: All 1436 eligible patients were randomized at the center level (mean age, 61.5 years; 99% women; 18% Asian, 17% Black, 26% Hispanic, and 37% White) and were followed up to the end of the study, insurance disenrollment, or death. Groups were similar in demographic and tumor characteristics. For the primary outcome, 7.9% (59 of 744) of patients at tailored sites were referred compared with 0.1% (1 of 692) at education-only sites (difference, 7.8%; 95% CI, 5.8%-9.8%). Referrals to a behavioral health clinician were completed by 44 of 59 patients treated at the intervention sites (75%) intervention sites vs 1 of 1 patient at the education-only sites (100%). In adjusted models patients at tailored sites had significantly fewer outpatient visits in medical oncology (rate ratio, 0.86; 95% CI, 0.86-0.89; P = .001), and no significant difference in utilization of primary care, urgent care, and emergency department visits. CONCLUSIONS AND RELEVANCE: Among patients with breast cancer treated in community-based oncology practices, tailored strategies for implementation of routine depression screening compared with an education-only control group resulted in a greater proportion of referrals to behavioral care. Further research is needed to understand the clinical benefit and cost-effectiveness of this program. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02941614.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Hahn EE, Munoz-Plaza CE, Pounds D, et al. Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial. JAMA. 2022. PMID: 34982119. doi:10.1001/jama.2021.22596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。